Gut microbiota ecosystem and host-microbiota interface

The gut microbiota ecosystem and host-microbiota interface represent the complex community of microorganisms inhabiting the gastrointestinal tract and their dynamic interactions with the host's epithelial and immune cells. This system plays a critical role in human health by facilitating nutrient metabolism, synthesizing essential vitamins, and training the host immune system to distinguish between commensal and pathogenic organisms (NIH, 2023). Dysbiosis, or an imbalance in this ecosystem, is linked to a wide range of conditions, including inflammatory bowel disease, metabolic disorders, and Clostridioides difficile infection (PubMed, 2022). Therapeutic interventions targeting this interface include probiotics, prebiotics, and fecal microbiota transplantation, which aim to restore a healthy microbial balance and strengthen the intestinal barrier. Recent advances in live biotherapeutic products (LBPs), such as Vowst and Rebyota, have further validated the gut microbiota as a viable target for treating recurrent infections (FDA, 2023). These therapies work by re-establishing ecological competition and modulating the production of bioactive metabolites like short-chain fatty acids.

Other names

Gut microbiomeIntestinal microbiotaGut-host interfaceGastrointestinal ecosystemIntestinal microflora

Modulation of microbial community structure to restore ecological balance, enhance mucosal barrier function, and regulate host metabolic and immune signaling pathways.